Analysts Offer Insights on Healthcare Companies: Incyte (INCY), Otsuka Holdings Co (OtherOTSKF) and AngioDynamics (ANGO)
Jefferies Adjusts Otsuka Holdings' Price Target to 10,500 Yen From 9,700 Yen, Keeps at Buy
Jefferies Adjusts Otsuka Holdings' Price Target to 9,700 Yen From 9,300 Yen, Keeps at Buy
Jefferies Adjusts Otsuka Holdings' Price Target to 9,300 Yen From 8,600 Yen, Keeps at Buy
Jefferies Adjusts Otsuka Holdings' Price Target to 8,600 Yen From 8,100 Yen, Keeps at Buy
Jefferies Adjusts Otsuka Holdings' Price Target to 8,100 Yen From 7,800 Yen, Keeps at Buy
Jefferies Adjusts Otsuka Holdings' Price Target to 7,800 Yen From 7,400 Yen, Keeps at Buy
Vertex Pharma Upgraded at Evercore on Alpine Immune Deal
Jefferies Adjusts Otsuka Holdings' Price Target to 7,400 Yen From 6,800 Yen, Keeps at Buy
Nomura Adjusts Otsuka Holdings' Price Target to 6,800 Yen From 6,500 Yen, Keeps at Buy
Jefferies Adjusts Otsuka Holdings' Price Target to 6,500 Yen From 5,700 Yen, Keeps at Buy
Jefferies Adjusts Otsuka Holdings' Price Target to 5,700 Yen From 4,900 Yen, Keeps at Buy
Jefferies Upgrades Otsuka Holdings to Buy From Hold, Adjusts Price Target to 4,900 Yen From 5,000 Yen
Otsuka Holdings Target Price Cut to Y4,900 From Y5,000 by Jefferies >4578.TO
No Data